Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydroc

Details Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydroc Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydroc

1992-05-20

1993-10-05

Ramsuer, Robert W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

5483591, 5483601, A61K 31415, C07D40506

Patent

active

052505618

ABSTRACT:
Compounds of the general formula I: ##STR1## are disclosed as useful in the treatment or prevention of hypercholesterolemia, hyperlipoproteinemia and atherosclerosis. Novel intermediate compounds used to make the compound of formula I are also disclosed.

REFERENCES:
patent: 4990529 (1991-02-01), Yamashita et al.

Affiliated with

Also associated with

Rating

Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydroc does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydroc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydroc will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1004272